2 "Ahmad Al-Hader, Md" clinical studies found.

• A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus Anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in ...

  This randomized phase II trial studies how well pembrolizumab with or without stereotactic body radiation therapy works in treating patients ...

  Exact  Phase N/A

• A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma

  This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage ...

  Exact